The Latest Breaking News from ADHD

The FDA approved an expanded indication for Supernus Pharmaceuticals Inc's (NASDAQ:SUPN) Qelbree (viloxazine extended-release capsules) for attention deficit hyperactivity disorder (ADHD) in adult patients aged 18 and older. The FDA has now approved Qelbree for ADHD in children (starting at age 6), adolescents, and adults. Qelbree is a novel non-stimulant taken once daily for…

Self-harm – physically hurting yourself – is common in young people, affecting about one in five teens by the age of 18.

The NHS is currently trialling new ways to cut waiting times

The NHS is trialling new ways to cut waiting times using a monitoring device to hasten diagnosis of irregular heart rhythms

Operations can have cognitive side-effects, particularly in the over-65s but also in the very young, where anaesthetic has been linked to ADHD. How can science minimise the danger?

This was the response when the actor famously left Downton Abbey at its height, fearful of being typecast as a floppy-haired aristo. Now based in LA, he’s starring in everything from comedy and horror to a new series about Watergate

NHS patients in England have a right to choose their service provider, including some private hospitals

BORIS JOHNSON has a lot on his plate at the moment, but it seems another photo is coming back to bite him. Last summer, the Prime Minister exchanged Penguin bars for Tim Tams with his Australian counterpart Scott Morrison as they posed for a photo-op after signing a post-Brexit trade…

Most cases are diagnosed between the ages of six and 12